Common integration sites for MMTV in viral induced mouse mammary tumors

Journal of Mammary Gland Biology and Neoplasia

Volumn 13, Issue 3, 2008, Pages 309-321

  Callahan, Robert ^a   Smith, Gilbert H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Mammary tumors; Mouse mammary tumor virus

Indexed keywords

FIBROBLAST GROWTH FACTOR; INITIATION FACTOR 3; NOTCH4 RECEPTOR; WNT PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; BREAST TUMOR; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; INBRED STRAIN; LONG TERMINAL REPEAT; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTAGENESIS; NONHUMAN; PRECANCER; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STEM CELL; STRAIN DIFFERENCE; VIRUS CARCINOGENESIS;

ANIMALS; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MODELS, BIOLOGICAL; MUTAGENESIS; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 50849124804     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-008-9092-6     Document Type: Article

References (86)

1. Kamiya K, Gould MN, Clifton KH. Quantitative studies of ductal versus alveolar differentiation from rat mammary clonogens. Proc Soc Exp Biol Med 1998;219(3):217-25.
2. Stingl J, Eaves CJ, Zandieh I, Emerman JT. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 2001;67(2):93-109. doi: 10.1023/A:1010615124301.
3. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439(7079):993-7.
4. Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 1996;39(1):21-31. doi: 10.1007/BF01806075.
5. Medina D. The preneoplastic phenotype in murine mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2000;5(4):393-407. doi: 10.1023/ A:1009529928422.
6. Medina D. Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 2005;12(3):483-95. doi: 10.1677/erc.1.00804.
7. Callahan R, Smith GH. MMTV-induced mammary tumorigenesis: Gene discovery, progression to malignancy and cellular pathways. Oncogene 2000;19(8):992-1001. doi: 10.1038/sj.onc.1203276.
8. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998;125(10):1921-30.
9. Smith GH, Boulanger CA. Mammary stem cell repertoire: New insights in aging epithelial populations. Mech Ageing Dev 2002;123:1505-19. doi: 10.1016/S0047-6374(02)00114-8.
10. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 2007;9(1):R12. doi: 10.1186/ bcr1645.
11. Gattelli A, Zimberlin MN, Meiss RP, Castilla LH, Kordon EC. Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines. J Virol 2006;80(22):11409-15. doi: 10.1128/ JVI.00234-06.
12. Lee AE. Genetic and viral influences of mammary tumours in BR6 mice. Br J Cancer 1968;22(1):77-82.
13. Squartini F. Responsiveness and progression of mammary tumors in high-cancer-strain mice. J Natl Cancer Inst 1962;28:911-26.
14. van Nie R, Verstraeten AA. Studies of genetic transmission of mammary tumour virus by C3Hf mice. Int J Cancer 1975;16(6):922-31. doi: 10.1002/ ijc.2910160606.
15. Foulds L. The histologic analysis of mammary tumors of mice. J Natl Cancer Inst 1956;17(6):701-801.
16. Squartini F. Tumours of the mammary gland. IARC Sci Publ 1979;23:43-90.
17. Squartini F, Basolo F, Bistocchi M. Lobuloalveolar differentiation and tumorigenesis: Two separate activities of mouse mammary tumor virus. Cancer Res 1983;43(12 Pt 1):5879-82.
18. Cairns J. Mutation selection and the natural history of cancer. Nature 1975;255(5505):197-200. doi: 10.1038/255197a0.
19. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A 2002;99(16):10567-70. doi: 10.1073/pnas.162369899.
20. Smith GH. Label-retaining mammary epithelial cells divide asymmetrically and retain their template DNA strands. Development 2005;132:681-7. doi: 10.1242/dev.01609.
21. Booth BW, Smith GH. Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res 2006;8(4):R49. doi: 10.1186/bcr1538.
22. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982;31(1):99-109. doi: 10.1016/0092-8674(82)90409-3.
23. Peters G, Brookes S, Smith R, Dickson C. Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors. Cell 1983;33(2):369-77. doi: 10.1016/ 0092-8674(83)90418-X.
24. Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 2004;23(36):6047-55. doi: 10.1038/sj.onc.1207816.
25. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, et al. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 2007;39(6):759-69. doi: 10.1038/ng2034.
26. Lazo PA, Lee JS, Tsichlis PN. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc Natl Acad Sci U S A 1990;87(1):170-3. doi: 10.1073/ pnas.87.1.170.
27. Gallahan D, Callahan R. Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J Virol 1987;61(1):66-74.
28. Marchetti A, Buttitta F, Miyazaki S, Gallahan D, Smith GH, Callahan R. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 1995;69(3):1932-8.
29. Lowther W, Wiley K, Smith GH, Callahan R. A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol 2005;79(15):10093-6. doi: 10.1128/ JVI.79.15.10093-10096.2005.
30. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002;32(1):153-9. doi: 10.1038/ ng950.
31. Qureshi SJ, Porteous DJ, Brookes AJ. Alu-based vectorettes and splinkerettes. More efficient and comprehensive polymerase chain reaction amplification of human DNA from complex sources. Genet Anal Tech Appl 1994;11(4):95-101. doi: 10.1016/1050-3862(94)90046-9.
32. Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci U S A 1995;92(6):2268-72. doi: 10.1073/pnas.92.6.2268.
33. Silver J, Keerikatte V. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J Virol 1989;63(5):1924-8.
34. Gallahan D, Callahan R. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 1997;14(16):1883-90. doi: 10.1038/sj.onc.1201035.
35. Sarkar NH, Haga S, Lehner AF, Zhao W, Imai S, Moriwaki K. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: Normal-and tumor-tissue-specific expression of int-3 transcripts. Virology 1994;203(1):52-62. doi: 10.1006/viro.1994.1454.
36. Peters G. Oncogenes at viral integration sites. Cell Growth Differ 1990;1(10):503-10.
37. Fehse B, Roeder I. Insertional mutagenesis and clonal dominance: biological and statistical considerations. Gene Ther 2008;15(2):143-53. doi: 10.1038/sj.gt.3303052.
38. Wu X, Luke BT, Burgess SM. Redefining the common insertion site. Virology 2006;344(2):292-5. doi: 10.1016/j.virol.2005.08.047.
39. Mohinta S, Wu H, Chaurasia P, Watabe K. Wnt pathway and breast cancer. Front Biosci 2007;12:4020-33. doi: 10.2741/2368.
40. Smolich BD, McMahon JA, McMahon AP, Papkoff J. Wnt family proteins are secreted and associated with the cell surface. Mol Biol Cell 1993;4(12):1267-75.
41. Hendrickx M, Leyns L. Non-conventional frizzled ligands and Wnt receptors. Dev Growth Differ 2008;50(4):229-43.
42. Binnerts ME, Kim KA, Bright JM, Patel SM, Tran K, Zhou M, et al. R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc Natl Acad Sci U S A 2007;104(37):14700-5. doi: 10.1073/ pnas.0702305104.
43. Kikuchi A, Yamamoto H. Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 2008;99(2):202-8. doi: 10.1111/j.1349-7006.2007.00675.x.
44. Cotton LM, O'Bryan MK, Hinton BT. Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev 2008;29(2):193-216. doi: 10.1210/er.2007-0028.
45. Dillon C, Spencer-Dene B, Dickson C. A crucial role for fibroblast growth factor signaling in embryonic mammary gland development. J Mammary Gland Biol Neoplasia 2004;9(2):207-15. doi: 10.1023/ B:JOMG.0000037163.56461.1e.
46. Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004;9(2):145-63. doi: 10.1023/B:JOMG.0000037159.63644.81.
47. Muskavitch MA. Delta-notch signaling and Drosophila cell fate choice. Dev Biol 1994;166(2):415-30. doi: 10.1006/dbio.1994.1326.
48. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. Notch4/ int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 1996;122(7):2251-9.
49. Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: A member of the notch gene family transforms mammary epithelial cells. J Virol 1992;66(4):2594-9.
50. Dievart A, Beaulieu N, Jolicoeur P. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 1999;18(44):5973-81. doi: 10.1038/sj.onc.1202991.
51. Struhl G, Fitzgerald K, Greenwald I. Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo. Cell 1993;74(2):331-45. doi: 10.1016/0092-8674(93)90424-O.
52. Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, et al. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res 1996;56(8):1775-85.
53. Hu C, Dievart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 2006;168(3):973-90. doi: 10.2353/ajpath.2006.050416.
54. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino G, et al. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev 1992;6(3):345-55. doi: 10.1101/ gad.6.3.345.
55. Smith GH, Gallahan D, Diella F, Jhappan C, Merlino G, Callahan R. Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ 1995;6(5):563-77.
56. Asano K, Merrick WC, Hershey JW. The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome. J Biol Chem 1997;272(38):23477-80. doi: 10.1074/jbc.272.38.23477.
57. Diella F, Levi G, Callahan R. Characterization of the INT6 mammary tumor gene product. DNA Cell Biol 1997;16(7):839-47.
58. Miyazaki S, Rasmussen S, Imatani A, Diella F, Sullivan DT, Callahan R. Characterization of the Drosophila ortholog of mouse eIF-3p48/INT-6. Gene 1999;233(1-2):241-7. doi: 10.1016/S0378-1119(99)00130-4.
59. Mayeur GL, Hershey JW. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett 2002;514(1):49-54. doi: 10.1016/S0014-5793(02)02307-4.
60. Rasmussen SB, Kordon E, Callahan R, Smith GH. Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene 2001;20(38):5291-301. doi: 10.1038/sj.onc.1204624.
61. Mack DL, Boulanger CA, Callahan R, Smith GH. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis. Breast Cancer Res 2007;9(4):R42. doi: 10.1186/bcr1742.
62. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Callahan R. Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol 2001;18(1):175-9.
63. Buttitta F, Martella C, Barassi F, Felicioni L, Salvatore S, Rosini S, et al. Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin Cancer Res 2005;11(9):3198-204. doi: 10.1158/1078-0432.CCR-04-2308.
64. Escot C, Hogg E, Callahan R. Mammary tumorigenesis in feral Mus cervicolor popaeus. J Virol 1986;58(2):619-25.
65. Marchetti A, Robbins J, Campbell G, Buttitta F, Squartini F, Bistocchi M, et al. Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. J Virol 1991;65(8):4550-4.
66. Kapoun AM, Shackleford GM. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Oncogene 1997;14(24):2985-9. doi: 10.1038/sj.onc.1201146.
67. Shackleford GM, MacArthur CA, Kwan HC, Varmus HE. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proc Natl Acad Sci U S A 1993;90(2):740-4. doi: 10.1073/pnas.90.2.740.
68. Kwan H, Pecenka V, Tsukamoto A, Parslow TG, Guzman R, Lin TP, et al. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol 1992;12(1):147-54.
69. Chatterjee G, Rosner A, Han Y, Zelazny ET, Li B, Cardiff RD, et al. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: Influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Am J Pathol 2002;161(6):2241-53.
70. Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, et al. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Cancer Res 2001;61(24):8811-9.
71. Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS. Cooperating oncogenic events in murine mammary tumorigenesis: Assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Exp Mol Pathol 2001;70(3):183-93. doi: 10.1006/exmp.2001.2357.
72. Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ, Ried T. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene 2002;21(6):890-8. doi: 10.1038/ sj.onc.1205146.
73. Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003;63(9):2179-87.
74. Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schrock E, et al. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Genes Chromosomes Cancer 1999;25(3):251-60. doi: 10.1002/ (SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3.
75. Podsypanina K, Li Y, Varmus HE. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. BMC Med 2004;2:24. doi: 10.1186/1741-7015-2-24.
76. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347(25):1999-2009. doi: 10.1056/NEJMoa021967.
77. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318(5853):1108-13. doi: 10.1126/science.1145720.
78. Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000;6(4):1273-8.
79. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, et al. Identification of a proviral structure in human breast cancer. Cancer Res 2001;61(4):1754-9.
80. Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res 2001;7(2):283-4.
81. Wang Y, Go V, Holland JF, Melana SM, Pogo BG. Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer. Clin Cancer Res 1998;4(10):2565-8.
82. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, et al. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res 1995;55(22):5173-9.
83. Wang Y, Jiang JD, Xu D, Li Y, Qu C, Holland JF, et al. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res 2004;64(12):4105-11. doi: 10.1158/ 0008-5472.CAN-03-3880.
84. Zammarchi F, Pistello M, Piersigilli A, Murr R, Di Cristofano C, Naccarato AG, et al. MMTV-like sequences in human breast cancer: A fluorescent PCR/laser microdissection approach. J Pathol 2006;209(4):436-44. doi: 10.1002/path.1997.
85. Melana SM, Nepomnaschy I, Sakalian M, Abbott A, Hasa J, Holland JF, et al. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res 2007;67(18):8960-5. doi: 10.1158/0008-5472.CAN-06-3892.
86. Indik S, Gunzburg WH, Kulich P, Salmons B, Rouault F. Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology 2007;4:73. doi: 10.1186/1742-4690-4-73.